NASDAQ:FPRX
Delisted
Five Prime Therapeutics Stock News
$38.00
+0 (+0%)
At Close: May 27, 2022
Five Prime's Stock Quadruples On Positive Mid-Stage Stomach Cancer Study
09:25am, Wednesday, 11'th Nov 2020
Five Prime Therapeutics Inc (NASDAQ: FPRX) shares are seeing astronomical gains Wednesday in reaction to a positive data readout. What Happened: Bemarituzumab, a targeted therapy, in combination with
Five Prime Therapeutics soars 386% after positive cancer trial results (FPRX)
09:02am, Wednesday, 11'th Nov 2020
A potential breakthrough in the treatment of stomach cancer helped boost shares of Five Prime Therapeutics higher by as much as 386% to $26.00 in Tuesday pre-market trades. The small-cap biotechnology
Why Five Prime Therapeutics Stock Is on Fire Today
08:30am, Wednesday, 11'th Nov 2020
The biotech's stomach cancer drug hit the mark in a midstage trial.
Five Prime's stock rockets fourfold after positive trial results from cancer treatment, analyst upgrade
07:05am, Wednesday, 11'th Nov 2020
Shares of Five Prime Therapeutics Inc. blasted 314% higher in premarket trading Wednesday, after the company said its treatment for gastric cancer met all three of its efficacy endpoints from Phase 2
Five Prime Therapeutics, Inc. (FPRX) CEO Tom Civik on Q3 2020 Results - Earnings Call Transcript
10:18pm, Tuesday, 03'rd Nov 2020
Five Prime Therapeutics, Inc. (FPRX) CEO Tom Civik on Q3 2020 Results - Earnings Call Transcript
Five Prime Therapeutics, Inc. (FPRX) CEO Tom Civik on Q3 2020 Results - Quick Version Earnings Call Transcript
06:11pm, Tuesday, 03'rd Nov 2020
Five Prime Therapeutics, Inc. (FPRX) CEO Tom Civik on Q3 2020 Results - Quick Version Earnings Call Transcript
Recap: Five Prime Therapeutics Q3 Earnings
04:21pm, Tuesday, 03'rd Nov 2020
Shares of Five Prime Therapeutics (NASDAQ:FPRX) were unchanged in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share increased 28.16% over the past year
Five Prime Therapeutics Announces Timing of Its Third Quarter 2020 Results Conference Call
10:29pm, Tuesday, 27'th Oct 2020
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Five Prime Therapeutics Announces Timing of Its Third Quarter 2020 Results Conference Call
Five Prime Therapeutics (FPRX) Presents At Wells Fargo Securities 2020 Virtual Healthcare Conference - Slideshow
05:39pm, Friday, 11'th Sep 2020
The following slide deck was published by Five Prime Therapeutics, Inc. in conjunction with this event..
3 Healthcare Stocks Under $10 With Massive Upside Ahead
07:30pm, Thursday, 13'th Aug 2020
Which stocks are leading the pack out on Wall Street? Biotechs. Understandably, investors have taken a more cautious approach when navigating the confused financial environment, but focus is locking i
Do Institutions Own Five Prime Therapeutics, Inc. (NASDAQ:FPRX) Shares?
04:56pm, Monday, 10'th Aug 2020
A look at the shareholders of Five Prime Therapeutics, Inc. (NASDAQ:FPRX) can tell us which group is most powerful...
What Type Of Shareholders Own The Most Number of Five Prime Therapeutics, Inc. (NASDAQ:FPRX) Shares?
04:55pm, Monday, 10'th Aug 2020
If you want to know who really controls Five Prime Therapeutics, Inc. (NASDAQ:FPRX), then you'll have to look at the...
Five Prime Therapeutics (FPRX) Reports Q2 Loss, Misses Revenue Estimates
12:30am, Friday, 07'th Aug 2020
Five Prime Therapeutics (FPRX) delivered earnings and revenue surprises of 31.43% and -22.76%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock
Five Prime Therapeutics Reports Second Quarter 2020 Results
08:05pm, Thursday, 06'th Aug 2020
Five Prime Therapeutics Reports Second Quarter 2020 Results
Five Prime Therapeutics (FPRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
04:33pm, Thursday, 30'th Jul 2020
Five Prime Therapeutics (FPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
